These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19593318)

  • 1. Updating the assessment of cardiac risk: beyond Framingham.
    Borden WB; Davidson MH
    Rev Cardiovasc Med; 2009; 10(2):63-71. PubMed ID: 19593318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores.
    Dhaliwal SS; Welborn TA
    Am J Cardiol; 2009 May; 103(10):1403-7. PubMed ID: 19427436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
    Vogel RA; Benitez RM
    Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.
    Scheltens T; Verschuren WM; Boshuizen HC; Hoes AW; Zuithoff NP; Bots ML; Grobbee DE
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):562-6. PubMed ID: 18756178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors. Insights from Framingham Heart Study].
    O'Donnell CJ; Elosua R
    Rev Esp Cardiol; 2008 Mar; 61(3):299-310. PubMed ID: 18361904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UKPDS-modelling of cardiovascular risk assessment and lifetime simulation of outcomes.
    Adler AI
    Diabet Med; 2008 Aug; 25 Suppl 2():41-6. PubMed ID: 18717978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific prediction of cardiac disease: importance of risk factors and exercise variables.
    D'Amore S; Mora S
    Cardiol Rev; 2006; 14(6):281-5. PubMed ID: 17053374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples.
    Bernini P; Bertini I; Luchinat C; Tenori L; Tognaccini A
    J Proteome Res; 2011 Nov; 10(11):4983-92. PubMed ID: 21902250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation in autoimmune diseases: algorithm for cardiovascular assessment.
    Miniati I; Conforti ML; Bernardo P; Tyndall A; Gensini GF; Matucci-Cerinic M
    Herz; 2007 Feb; 32(1):43-50. PubMed ID: 17323034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation.
    Zomer E; Owen A; Magliano DJ; Liew D; Reid C
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):115-20. PubMed ID: 20473180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of cardiovascular disease].
    Katić T; Sakić I; Bergovec M
    Acta Med Croatica; 2009 Feb; 63(1):71-4. PubMed ID: 19681467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk: its assessment in clinical practice.
    Wilson SL; Poulter NR
    Br J Biomed Sci; 2001; 58(4):248-51. PubMed ID: 11788004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.
    Cooney MT; Dudina AL; Graham IM
    J Am Coll Cardiol; 2009 Sep; 54(14):1209-27. PubMed ID: 19778661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk].
    Giudicelli CP; Chanudet X
    Bull Acad Natl Med; 2004; 188(3):401-11; discussion 412-4. PubMed ID: 15584652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors: hemorheologic and hemostatic components.
    Martins e Silva J; Saldanha C
    Rev Port Cardiol; 2007 Feb; 26(2):161-82. PubMed ID: 17479711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk functions and the primary prevention of cardiovascular disease].
    Grau M; Marrugat J
    Rev Esp Cardiol; 2008 Apr; 61(4):404-16. PubMed ID: 18405521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.